Article Text

Download PDFPDF
Abstracts from the Association of British Neurologists Annual Meeting 2011
097 Valosin Containing Protein (VCP) and Myofibrillar Myopathies (MFM) genes' mutations are not associated with sporadic Inclusion Body Myositis (sIBM)
  1. P Machado,
  2. J Hudson,
  3. A Miller,
  4. J Morrow,
  5. M Parton,
  6. K Bushby,
  7. M Hanna
  1. MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology,
  2. Institute of Genetic Medicine, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK


Background Inclusion body myopathy with dementia and Paget disease of bone (IBMPFD) and myofibrillar myopathies (MFM) are genetically determined myopathies that can mimic sporadic Inclusion Body Myositis (sIBM), especially if the disease phenotype is incomplete (eg, skeletal muscle involvement only), if there is no family history (either because a mutation arises in the germ line or because the disease in the parents was unrecognised) and if the histological features overlap with those of sIBM. It is therefore possible that some sIBM cases may be caused by undetected mutations in the IBMPFD and MFM causative genes.

Objective To investigate the association of sIBM with mutations in the IBMPFD and MFM causative genes.

Methods Twenty-nine patients with sIBM (meeting diagnostic criteria for definite or probable sIBM according to Griggs) were screened for mutations in the following genes: valosin containing protein (VCP), Desmin (DES), Myotilin (MYOT) and Crystallin alpha-B (CRYAB).

Results No pathogenic mutations in the VCP, DES, MYOT and CRYAB genes were detected in this group of sIBM patients.

Conclusion This study provides evidence that common mutations in the VCP, DES, MYOT and CRYAB genes are not associated with the development of sIBM. Our results support current clinical practice in patients with sIBM, which are not usually screened for mutations in these genes, unless there the history or biopsy findings suggest a genetically determined myopathy.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Email: p.machado{at}